Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK

Journal article

Buckell J. et al, (2023), Scientific Reports, 13

Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

Journal article

Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

Journal article

Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337

Automated 96-well format high throughput colony formation assay for siRNA library screen

Journal article

Hatch SB. et al, (2022), STAR Protocols, 3, 101355 - 101355

CHK1 inhibition exacerbates replication stress induced by IGF blockade

Journal article

Wu X. et al, (2022), Oncogene, 41, 476 - 488

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

Journal article

Walker AS. et al, (2021), New England Journal of Medicine, 385, 2582 - 2585

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections

Journal article

Eyre DW. et al, (2021), BMC Infectious Diseases, 21

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

Journal article

Abdelhady H. et al, (2021), JAMA, 326, 1690 - 1690

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Journal article

Wei J. et al, (2021), Nature Communications, 12

Load More